Ascaridia galli Large Roundworm in Poultry: Clinical Impact and Anthelmintic Strategies

Introduction

Ascaridia galli is the most prevalent and economically significant large intestinal roundworm of domestic chickens and turkeys worldwide. This ascarid nematode belongs to the family Ascaridiidae and inhabits the small intestine of galliform birds. Heavy infections cause reduced weight gain, decreased egg production, intestinal obstruction, and increased mortality in severe cases. The parasite directly competes with the host for nutrients and can cause mucosal damage leading to secondary bacterial infections. Understanding the biology, clinical impact, and rational anthelmintic strategies for Ascaridia galli large roundworm poultry treatment is essential for sustainable flock health management.

Etiology and Life Cycle

Ascaridia galli is a large, whitish nematode. Adult females measure 50 to 60 mm in length; males are slightly smaller at 30 to 50 mm. The life cycle is direct, involving no intermediate host. Adult worms reside in the lumen of the small intestine, primarily the jejunum and ileum. Females produce thick-shelled, oval, unembryonated eggs that are passed in the feces. Under optimal environmental conditions (20 to 30 degrees Celsius, adequate moisture, oxygen), the eggs embryonate and develop to the infective third-stage larva (L3) within 10 to 14 days. Infective eggs are resistant to desiccation and can survive in litter or soil for months to years.

After ingestion by a susceptible bird, the eggs hatch in the proventriculus or duodenum. Larvae undergo two molts within the intestinal mucosa over 3 to 7 days, causing histotropic damage. Prepatent period ranges from 24 to 30 days in chickens. The histotropic phase is critical for pathogenesis: larvae tunnel into the crypts of Lieberkuhn, disrupting villus architecture and absorptive capacity. Adult worms then emerge into the lumen, where they feed on intestinal contents and may cause mechanical irritation.

Epidemiology

Prevalence of Ascaridia galli is highest in free-range, backyard, and organic poultry systems where birds have continuous access to contaminated soil and litter. Confined indoor flocks with good biosecurity and regular litter removal have low infection rates. The parasite is endemic in many regions of Europe, Asia, Africa, and the Americas. A cross-sectional study by Akramova et al. [1] reported helminth diversity in domestic birds in Uzbekistan, with A. galli among the most prevalent nematodes, demonstrating the parasite's persistence under extensive management. Climatic factors, stocking density, age of birds, and immune status heavily influence transmission dynamics.

In a survey of European farmers and veterinarians, Mwangi et al. [2] noted that producers often underestimate the economic impact of subclinical roundworm infections. Many rely on routine, non-targeted anthelmintic treatments, contributing to selection for resistant populations. The concept of refugia, as modeled by Odeniran [3] for gastrointestinal nematodes of small ruminants, is equally applicable to poultry systems: maintaining a proportion of worms unexposed to anthelmintics (e.g., in untreated birds or on pasture) slows resistance development.

Clinical Signs and Pathology

Clinical disease (ascaridiosis) is most pronounced in young birds aged 3 to 10 weeks. Light infections are usually asymptomatic. Moderate to heavy worm burdens cause:

• Reduced feed conversion efficiency and weight gain.
• Listlessness, drooping wings, ruffled feathers.
• Diarrhea, sometimes with mucus or blood.
• Intestinal obstruction or rupture in massive infections.
• Secondary bacterial enteritis, particularly from Escherichia coli (see Escherichia coli in Chickens and Poultry Products).
• In laying hens: decreased egg production, poor shell quality, and increased mortality.

Pathologic lesions include catarrhal enteritis, petechiae on the mucosal surface, and thickening of the intestinal wall. During the histotropic phase, larvae cause necrosis and hemorrhage in the crypts. Chronic infections lead to villous atrophy and reduced absorptive surface area. The presence of adult worms may obstruct the intestinal lumen, causing impaction and secondary bacterial peritonitis.

Diagnosis

Antemortem diagnosis relies on fecal flotation techniques. A. galli eggs are oval, with a smooth, thick shell, measuring 70 to 90 micrometers by 40 to 50 micrometers. They have a single-cell or morulated embryo when freshly passed. Quantitative egg counts (modified McMaster technique) can estimate worm burden, but correlation is moderate due to variable fecundity and fecal output. Postmortem examination reveals adult worms in the small intestine; counting worms from a representative sample is the gold standard.

Molecular diagnostics, such as genus-specific PCR assays targeting ribosomal DNA (ITS-2 region), allow species identification and can detect prepatent infections. These techniques are increasingly used in research and high-throughput surveillance. For a broader discussion on diagnostic approaches for avian parasites, refer to Respiratory and Intestinal Nematodes of Poultry: Syngamus trachea, Ascaridia galli, Heterakis gallinarum, and Capillaria obsignata.

Anthelmintic Strategies

Effective treatment of Ascaridia galli large roundworm poultry requires a combination of chemotherapeutic agents, management practices, and resistance monitoring. Available anthelmintics include benzimidazoles (fenbendazole, flubendazole), levamisole, piperazine, and macrocyclic lactones (ivermectin, moxidectin). However, resistance is an emerging threat.

Benzimidazoles

Fenbendazole and flubendazole are the most commonly used benzimidazoles in poultry. They bind to beta-tubulin, inhibiting microtubule polymerization and disrupting glucose uptake in nematodes. These drugs are administered in feed over 5 to 7 consecutive days. Efficacy against adult and larval stages is high if resistance is absent. In flocks with suspected resistance, fecal egg count reduction tests (FECRT) should be performed before and after treatment.

Levamisole

Levamisole is a nicotinic acetylcholine receptor agonist causing spastic paralysis of worms. It is water-soluble and can be administered via drinking water. Resistance to levamisole is less documented in poultry than in ruminant nematodes, but cross-resistance with other cholinergic agonists is possible. Treatment is usually a single dose, but careful calculation of water consumption is critical to avoid underdosing.

Macrocyclic Lactones

Ivermectin and moxidectin are effective against adult A. galli but have variable activity against histotropic larvae. These drugs potentiate glutamate-gated chloride channels, leading to flaccid paralysis. In poultry, ivermectin is often used off-label; withdrawal periods must be observed for eggs and meat. Hellinga et al. [4] demonstrated in a Caenorhabditis elegans model that ivermectin resistance can evolve rapidly and is influenced by population size and genetic diversity, with possible cross-resistance to emodepside. This underscores the need for prudent use and rotation of drug classes.

Piperazine

Piperazine acts as a GABA agonist causing hyperpolarization and paralysis. It is less effective against immature stages and requires high doses. Resistance is now widespread in many swine and poultry systems, limiting its practical use.

Plant-Derived Anthelmintics

A promising area of research is the development of plant-derived anthelmintic agents. Kozan and Küpeli [5] reviewed mechanistic insights of phytochemicals such as tannins, saponins, and flavonoids that interfere with nematode energy metabolism, neuromuscular coordination, or cuticle integrity. In poultry, feeding of bioactive forages (e.g., chicory, sainfoin) may reduce A. galli burdens, but efficacy is variable and standardization is lacking. Roy and Lyndem [6] highlighted opportunities for targeting metabolic checkpoints in helminths, such as unique glycolytic enzymes or neurotransmitter receptors, using novel small molecules derived from natural products.

Anthelmintic Resistance

Resistance to benzimidazoles has been confirmed in A. galli populations on some European farms. Mechanisms include target-site mutations in beta-tubulin (e.g., F200Y, E198A), similar to those described in Haemonchus contortus by Nowek et al. [7]. For poultry, routine molecular surveillance of these polymorphisms is not yet common practice but would greatly enhance resistance management. Scala et al. [8] promoted the use of body condition score (BCS) as a targeted selective treatment (TST) criterion in sheep; analogous approaches in poultry (e.g., treating only birds with poor weight gain or low egg production) could reduce selection pressure while maintaining animal welfare.

Integrated Control Strategies

Sustainable control of A. galli relies on integration of anthelmintic use with management practices:

• Pasture and litter management: frequent removal of litter, rotation of outdoor runs, or fallowing periods to reduce egg contamination.
• Use of refugia: leaving a subset of birds untreated (when clinically justified) to maintain a susceptible worm population, as modeled by Odeniran [3] for small ruminant nematodes.
• Resistance testing: periodic FECRT or molecular assays to detect emerging resistance.
• Nutritional support: Babar et al. [9] reviewed evidence that polyunsaturated fatty acids (PUFAs) can modulate host immune responses and reduce nematode burdens, though field data in poultry are limited.

Nedrelid et al. [10] surveyed veterinary practitioners in Norway and found that knowledge of pasture-based parasite transmission and anthelmintic resistance varied considerably. Targeted educational programs for poultry farmers and veterinarians are needed to promote evidence-based treatment protocols.

The following decision tree outlines a framework for managing Ascaridia galli infections in commercial flocks:

flowchart TD
    A[Flock with suspected roundworm infection], > B{Clinical signs present?}
    B, >|Yes| C[Perform fecal egg count (McMaster)]
    B, >|No| D[Maintain routine monitoring every 4-6 weeks]
    C, > E[Egg count > 500 eggs per gram?]
    E, >|Yes| F[Select anthelmintic class based on history]
    E, >|No| G[No treatment; implement improved litter hygiene]
    F, > H[Administer treatment (e.g., fenbendazole 7-day in-feed)]
    H, > I[Perform FECRT 14 days post-treatment]
    I, > J{Reduction > 90%?}
    J, >|Yes| K[Rotate to different class next treatment cycle]
    J, >|No| L[Suspected resistance; confirm with molecular SNP testing]
    L, > M[Switch to alternative drug class or plant-based product]
    M, > N[Initiate integrated control: pasture rotation, refugia, nutrition]
    N, > O[Reassess in 6-8 weeks]
    O, > D

Comparative Considerations

Unlike some other poultry nematodes such as Heterakis gallinarum (which can transmit Histomonas meleagridis), A. galli does not vector other pathogens but predisposes birds to bacterial enteritis by disrupting mucosal integrity. Clinicians should differentiate A. galli infection from other causes of poor performance in broilers and layers, including coccidiosis, necrotic enteritis (see Necrotic Enteritis in Broiler Chickens), and viral enteropathies. Concomitant infections with E. coli or Salmonella (see Salmonella in Chickens) are common and should be addressed concurrently.

For a general framework on poultry parasite management, readers may consult Comprehensive Classification of Types of Chicken Parasites, which covers both ectoparasites and endoparasites.

Future Directions

Research on A. galli is advancing on several fronts. Bello et al. [11] demonstrated benefits of integrated control strategies in tropical settings for Haemonchus contortus in sheep; analogous principles apply to poultry roundworms. Ondrackova et al. [12] compared in vitro anthelmintic efficacy across Gyrodactylus species, highlighting the value of standardized bioassays that could be adapted for A. galli to screen novel compounds. Rees et al. [13] noted that farmers often perceive parasite control simply as "drench for it," not recognizing the complexities of resistance; this attitude must shift toward evidence-based, sustainable practices.

Decoding helminth metabolic pathways, as advocated by Roy and Lyndem [6], offers a rational route for developing new anthelmintics with high specificity and low toxicity for poultry. Plant-derived agents remain a promising but underutilized strategy [5], requiring rigorous in vivo validation and formulation standardization.

Table 1: Summary of Anthelmintic Options for Ascaridia galli

Table 2: Key Diagnostic Features of A. galli Eggs

Conclusion

Ascaridia galli remains a significant constraint to poultry production, particularly in systems with outdoor access. Effective Ascaridia galli large roundworm poultry treatment requires a dynamic balance between anthelmintic use, resistance management, and environmental hygiene. Routine fecal monitoring, FECRT, and judicious drug rotation are essential. Emerging strategies, including plant-derived anthelmintics and targeted selective treatment, offer pathways to sustainability. The integration of molecular diagnostics for resistance surveillance, as described for ruminant nematodes [7, 3], should be adapted for poultry to preserve the efficacy of current anthelmintics and safeguard future drug development.

References

[1] Akramova FD, Mirzaeva AU, Saidova SO, et al. Helminth diversity, prevalence, and host-specific patterns in wild and domestic ruminants of the Bukhara region, Uzbekistan. J Adv Vet Anim Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42180291/

[2] Mwangi HN, Lietaer L, Claerebout E, et al. Perceptions on the Economic Feasibility of Sustainable Roundworm Control Practices in Grazed Livestock-A Short Survey Among European Farmers and Veterinarians. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42193843/

[3] Odeniran PO. Region-specific modeling of refugia and anthelmintic resistance dynamics in gastrointestinal nematodes of Nigerian small ruminants. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034952/

[4] Hellinga J, Trubenova B, Wagner J, et al. Evolution of Ivermectin Resistance in the Nematode Model Caenorhabditis elegans: Critical Influence of Population Size and Altered Emodepside Efficacy. Evol Appl. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42038536/

[5] Kozan E, Küpeli E. Plant-derived anthelmintic agents in veterinary helminth control: Mechanistic insights and translational challenges. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42250411/

[6] Roy S, Lyndem LM. Decoding the metabolic checkpoints in helminths: Opportunities for novel anthelmintic drug development. Acta Trop. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42173387/

[7] Nowek Z, Mickiewicz M, Czopowicz M, et al. The prevalence of E198A and F200Y single nucleotide polymorphism in Haemonchus contortus populations from Polish goat herds. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42168555/

[8] Scala A, Tamponi C, Cavallo L, et al. Further evaluations on the use of body condition score as target selective treatment criterion to control subclinical gastrointestinal nematode infections on dairy sheep. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42172801/

[9] Babar M, Fatima G, Thamsborg SM, et al. Polyunsaturated Fatty Acids and Parasite Control: Toward Sustainable Anthelmintic Strategies within a One Health Framework. Anim Health Res Rev. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42112540/

[10] Nedrelid C, Gravdal M, Robertson LJ, et al. Veterinary practitioners' perspectives on pasture-transmitted parasites in Norwegian sheep and cattle: A questionnaire-based study. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034948/

[11] Bello HJS, Costa ECD, Cunha AFD, et al. Monitoring the second generation of lambs after Haemonchus contortus replacement in ewes: effects of climate, sheep breed, and integrated control strategies in the tropics. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42150799/

[12] Ondrackova M, Kolarova J, Skocovska K. In vitro comparison of anthelmintic efficacy across Gyrodactylus species. Vet Med (Praha). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146776/

[13] Rees GM, Evans SR, Davis CN, et al. "Not a problem because we drench for it": the management of liver fluke on sheep farms. Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42058560/